Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Effect of Local Antioxidant Therapy on Racial Differences in Vasoconstriction
NCT03680404Phase 1Completed
- Sponsor
- The University of Texas at Arlington
- Start
- Oct 2018
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of apocynin, allopurinol and tempol in vasoconstriction (4 arms), sponsored by The University of Texas at Arlington. Primary endpoints: Vasoconstrictor Responsiveness to Phenylephrine using Laser Doppler Fluxmetry at 1 year and Role of Oxidative Stress in Heightened Vasoconstriction using Laser Doppler Fluxmetry at 1 year. Started Oct 2018; status: completed.
02
Drugs
apocyninallopurinoltempol
03
Conditions
vasoconstriction
Beyond the preview
Go deeper on NCT03680404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03680404.